Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

被引：88

作者：

Tsao, Anne S. ^{[1
]}

Lindwasser, O. Wolf ^{[2
]}

Adjei, Alex A. ^{[3
]}

Adusumilli, Prasad S. ^{[4
]}

Beyers, Matthew L. ^{[5
]}

Blumenthal, Gideon M. ^{[6
]}

Bueno, Raphael ^{[7
]}

Burt, Bryan M. ^{[8
]}

Carbone, Michele ^{[9
]}

Dahlberg, Suzanne E. ^{[10
]}

de Perrot, Marc ^{[11
,12
]}

Fennell, Dean A. ^{[13
,14
]}

Friedberg, Joseph ^{[15
]}

Gill, Ritu R. ^{[16
]}

Gomez, Daniel R. ^{[17
]}

Harpole, David H., Jr. ^{[18
]}

Hassan, Raffit ^{[19
]}

Hesdorffer, Mary ^{[20
]}

Hirsch, Fred R. ^{[21
]}

Hmeljak, Julija ^{[22
]}

Kindler, Hedy L. ^{[23
]}

Korn, Edward L. ^{[24
]}

Liu, Geoffrey ^{[25
]}

Mansfield, Aaron S. ^{[3
]}

Nowak, Anna K. ^{[26
,27
]}

Pass, Harvey I. ^{[28
]}

Peikert, Tobias ^{[29
]}

Rimner, Andreas ^{[30
]}

Robinson, Bruce W. S. ^{[31
,32
]}

Rosenzweig, Kenneth E. ^{[33
]}

Rusch, Valerie W. ^{[4
]}

Salgia, Ravi ^{[34
]}

Sepesi, Boris ^{[35
]}

Simone, Charles B., II ^{[36
]}

Sridhara, Rajeshwari ^{[5
]}

Szlosarek, Peter ^{[37
]}

Taioli, Emanuela ^{[38
,39
]}

Tsao, Ming-Sound ^{[40
,41
]}

Yang, Haining ^{[8
]}

Zauderer, Marjorie G. ^{[42
]}

Malik, Shakun M. ^{[43
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

[2] NCI, Coordinating Ctr Clin Trials, NIH, Bethesda, MD 20892 USA

[3] Mayo Clin, Div Med Oncol, Rochester, MN USA

[4] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA

[5] Emmes Corp, Rockville, MD USA

[6] US FDA, Silver Spring, MD USA

[7] Brigham & Womens Hosp, Thorac Surg, 75 Francis St, Boston, MA 02115 USA

[8] Baylor Coll Med, Dept Surg, Div Thorac Surg, Houston, TX 77030 USA

[9] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA

[10] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA

[11] Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada

[12] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[13] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England

[14] Univ Hosp Leicester, Leicester, Leics, England

[15] Univ Maryland, Ctr Canc, Dept Thorac Surg, Baltimore, MD 21201 USA

[16] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA

[17] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA

[18] Duke Univ, Dept Surg, Div Cardiothorac Surg, Durham, NC USA

[19] NCI, Thorac & GI Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[20] Mesothelioma Appl Res Fdn, Alexandria, VA USA

[21] Univ Colorado, Ctr Canc, IASLC, Denver, CO 80262 USA

[22] Co Biologists, Cambridge, England

[23] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA

[24] NCI, Biometr Res Program, NIH, Bethesda, MD 20892 USA

[25] Princess Margaret Canc Ctr, Toronto, ON, Canada

[26] Univ Western Australia, Sch Med, Perth, WA, Australia

[27] Univ Western Australia, Natl Ctr Asbestos Related Dis, Perth, WA, Australia

[28] NYU, Dept Cardiothorac Surg, Langone Med Ctr, New York, NY USA

[29] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA

[30] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA

[31] Univ Western Australia, Natl Ctr Asbestos Related Dis, Nedlands, WA, Australia

[32] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia

[33] Mt Sinai Med Ctr, Dept Radiat Oncol, New York, NY 10029 USA

[34] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA

[35] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA

[36] Univ Maryland, Med Ctr, Dept Radiat Oncol, Baltimore, MD 21201 USA

[37] Queen Mary Univ London, Barts Canc Inst, London, England

[38] Icahn Sch Med Mt Sinai, Epidemiol, New York, NY 10029 USA

[39] Icahn Sch Med Mt Sinai, Dept Thorac Surg, New York, NY 10029 USA

[40] Univ Toronto, Dept Pathol, Toronto, ON, Canada

[41] Univ Toronto, Dept Pathol, Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada

[42] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[43] NCI, Clin Invest Branch, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 11期

基金：

美国国家卫生研究院;

关键词：

Malignant mesothelioma; Pleural; Clinical trials; Multimodality therapy; Targeted therapy; PHASE-II TRIAL; PEGYLATED ARGININE DEIMINASE; PLEURAL MESOTHELIOMA; EXTRAPLEURAL PNEUMONECTOMY; HEMITHORACIC RADIATION; SPONTANEOUS REGRESSION; MULTIMODALITY THERAPY; RECIST CRITERIA; DOUBLE-BLIND; SURVIVAL;

D O I：

10.1016/j.jtho.2018.08.2036

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

On March 28- 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting in Bethesda, Maryland. The goal of the meeting was to bring together lead academicians, clinicians, scientists, and the U.S. Food and Drug Administration to focus on the development of clinical trials for patients in whom malignant pleural mesothelioma has been diagnosed. In light of the discovery of new cancer targets affecting the clinical development of novel agents and immunotherapies in malignant mesothelioma, the objective of this meeting was to assemble a consensus on at least two or three practice-changing multimodality clinical trials to be conducted through NCI's National Clinical Trials Network. Crown Copyright (C) 2018 Published by Elsevier Inc.

引用

页码：1655 / 1667

页数：13

共 107 条

[1] Immunotherapy and radiation therapy for malignant pleural mesothelioma
Alley, Evan W.
Katz, Sharyn I.
Cengel, Keith A.
Simone, Charles B., II
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (02) : 212 - 219
[2] Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma
Anraku, Masaki
Cunningham, Kristopher S.
Yun, Zhihong
Tsao, Ming-Sound
Zhang, Li
Keshavjee, Shaf
Johnston, Michael R.
de Perrot, Marc
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 135 (04) : 823 - 829
[3] Thalidomide in patients with malignant pleural mesothelioma
Baas, P
Boogerd, W
Dalesio, O
Haringhuizen, A
Custers, F
van Zandwijk, N
[J]. LUNG CANCER, 2005, 48 (02) : 291 - 296
[4] The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada
Baumann, Francine
Buck, Brenda J.
Metcalf, Rodney V.
McLaurin, Brett T.
Merkler, Douglas J.
Carbone, Michele
[J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (05) : 731 - 737
[5] Asbestos is not just asbestos: an unrecognised health hazard
Baumann, Francine
Ambrosi, Jean-Paul
Carbone, Michele
[J]. LANCET ONCOLOGY, 2013, 14 (07) : 576 - 578
[6] Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers
Beddowes, Emma
Spicer, James
Chan, Pui Ying
Khadeir, Ramsay
Corbacho, Javier Garcia
Repana, Dimitra
Steele, Jeremy P.
Schmid, Peter
Szyszko, Teresa
Cook, Gary
Diaz, Monica
Feng, Xiaoxing
Johnston, Amanda
Thomson, Jim
Sheaff, Michael
Wu, Bor-Wen
Bomalaski, John
Pacey, Simon
Szlosarek, Peter W.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) : 1778 - +
[7] Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
Blumenthal, Gideon M.
Kluetz, Paul G.
Schneider, Julie
Goldberg, Kirsten B.
McKee, Amy E.
Pazdur, Richard
[J]. ONCOLOGIST, 2017, 22 (07) : 762 - 767
[8] Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
Bononi, Ilaria
Comar, Manola
Puozzo, Andrea
Stendardo, Mariarita
Boschetto, Piera
Orecchia, Sara
Libener, Roberta
Guaschino, Roberto
Pietrobon, Silvia
Ferracin, Manuela
Negrini, Massimo
Martini, Fernanda
Bovenzi, Massimo
Tognon, Mauro
[J]. ONCOTARGET, 2016, 7 (50) : 82700 - 82711
[9] Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Bueno, Raphael
Stawiski, Eric W.
Goldstein, Leonard D.
Durinck, Steffen
De Rienzo, Assunta
Modrusan, Zora
Gnad, Florian
Nguyen, Thong T.
Jaiswal, Bijay S.
Chirieac, Lucian R.
Sciaranghella, Daniele
Dao, Nhien
Gustafson, Corinne E.
Munir, Kiara J.
Hackney, Jason A.
Chaudhuri, Amitabha
Gupta, Ravi
Guillory, Joseph
Toy, Karen
Ha, Connie
Chen, Ying-Jiun
Stinson, Jeremy
Chaudhuri, Subhra
Zhang, Na
Wu, Thomas D.
Sugarbaker, David J.
de Sauvage, Frederic J.
Richards, William G.
Seshagiri, Somasekar
[J]. NATURE GENETICS, 2016, 48 (04) : 407 - +
[10] Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
Byrne, MJ
Nowak, AK
[J]. ANNALS OF ONCOLOGY, 2004, 15 (02) : 257 - 260

← 1 2 3 4 5 6 7 8 9 10 →